Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.

Koh CH, Lee HS, Chung SK.

Cornea. 2014 May;33(5):527-32. doi: 10.1097/ICO.0000000000000104.

PMID:
24608256
2.

The effect of topical infliximab on corneal neovascularization in rabbits.

Kim JW, Chung SK.

Cornea. 2013 Feb;32(2):185-90. doi: 10.1097/ICO.0b013e318271cc2a.

PMID:
23146933
3.

The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.

Lee YK, Chung SK.

Cornea. 2013 Aug;32(8):1142-8. doi: 10.1097/ICO.0b013e318292a79d.

PMID:
23739149
4.

Treatment of corneal neovascularization by topical application of ascorbic acid in the rabbit model.

Lee MY, Chung SK.

Cornea. 2012 Oct;31(10):1165-9. doi: 10.1097/ICO.0b013e318241433b.

PMID:
22832865
5.

The effect of curcumin on corneal neovascularization in rabbit eyes.

Kim JS, Choi JS, Chung SK.

Curr Eye Res. 2010 Apr;35(4):274-80. doi: 10.3109/02713680903528345.

PMID:
20373893
6.

The effect of bevacizumab on corneal neovascularization in rabbits.

Kim WJ, Jeong HO, Chung SK.

Korean J Ophthalmol. 2010 Aug;24(4):230-6. doi: 10.3341/kjo.2010.24.4.230. Epub 2010 Aug 3.

7.

Inhibitory Effect of Topical Aflibercept on Corneal Neovascularization in Rabbits.

Park YR, Chung SK.

Cornea. 2015 Oct;34(10):1303-7. doi: 10.1097/ICO.0000000000000507.

PMID:
26114826
8.

KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.

Li T, Hu A, Li S, Luo Y, Huang J, Yu H, Ma W, Pan J, Zhong Q, Yang J, Wu J, Tang S.

Mol Vis. 2011 Mar 25;17:797-803.

9.

Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.

Park JH, Joo CK, Chung SK.

Cornea. 2015 Apr;34(4):449-55. doi: 10.1097/ICO.0000000000000336.

PMID:
25651492
10.

Inhibition of corneal angiogenesis by local application of vasostatin.

Wu PC, Yang LC, Kuo HK, Huang CC, Tsai CL, Lin PR, Wu PC, Shin SJ, Tai MH.

Mol Vis. 2005 Jan 13;11:28-35.

11.

Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model.

Pérez-Santonja JJ, Campos-Mollo E, Lledó-Riquelme M, Javaloy J, Alió JL.

Am J Ophthalmol. 2010 Oct;150(4):519-528.e1. doi: 10.1016/j.ajo.2010.04.024. Epub 2010 Jun 29.

PMID:
20591397
12.

The effect of subconjunctival suramin on corneal neovascularization in rabbits.

Lee HS, Chung SK.

Cornea. 2010 Jan;29(1):86-92. doi: 10.1097/ICO.0b013e3181ae91e3.

PMID:
19907290
13.

[Efficacy of epigallocatechin gallate in treatment of alkali burn injury of murine cornea].

Wu LQ, Lu M.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Jan;44(1):15-23. Chinese.

PMID:
25851970
14.

Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits.

Yoo AR, Chung SK.

Cornea. 2014 Oct;33(10):1088-94. doi: 10.1097/ICO.0000000000000220.

PMID:
25119962
15.

Effects of Combined Photodynamic Therapy and Topical Bevacizumab Treatment on Corneal Neovascularization in Rabbits.

Kim RY, Chung SK, Kim MS, Ra H.

Cornea. 2016 Dec;35(12):1615-1620. doi: 10.1097/ICO.0000000000001016.

PMID:
27684458
16.

Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.

Papathanassiou M, Theodossiadis PG, Liarakos VS, Rouvas A, Giamarellos-Bourboulis EJ, Vergados IA.

Am J Ophthalmol. 2008 Mar;145(3):424-431. doi: 10.1016/j.ajo.2007.11.003. Epub 2008 Jan 22.

PMID:
18207123
17.

Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).

Kim TI, Kim SW, Kim S, Kim T, Kim EK.

Cornea. 2008 Apr;27(3):349-52. doi: 10.1097/ICO.0b013e31815cf67d.

PMID:
18362666
18.

Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.

Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z.

Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4062-71.

PMID:
16249481
19.

A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.

Zuo L, Fan Y, Wang F, Gu Q, Xu X.

Curr Eye Res. 2010 May;35(5):375-84. doi: 10.3109/02713681003597230.

PMID:
20450250
20.

Supplemental Content

Support Center